Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...

Anticoagulation therapy is essential for managing patients with AF, as it helps prevent blood clots that can lead to strokes. Recent research has focused on improving treatment guidelines ...

Interruption of long-term anticoagulation therapy for elective, planned urologic procedures in these patients creates a complex situation in which competing risks of thrombosis and hemorrhage must ...

Abnormal uterine bleeding (AUB) is a significant concern for women of reproductive age, particularly those on anticoagulant therapy. Anticoagulants, which are medications that help prevent blood ...

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

Extracorporeal therapy (ECT) is a method of blood purification performed to remove a pathogenic substance, or solute, from ...

These documents have become too technical, too inconsistent, and rely too much on expert opinion, Marco Valgimigli argues.

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...